Your only treatment of mesothelioma news source!
Click on each item to read full story.

 
New Report May Help Doctors Predict Chemotherapy Success, According to Surviving Mesothelioma
read story
Japanese research suggests a biomarker called osteopontin could help some mesothelioma patients avoid the trial-and-error approach to treatment. (PRWeb April 19, 2014) Read the full story at http://www.prweb.com/releases/2014/04/prweb11757804.htm
 
Research and Markets: Global Malignant Mesothelioma Clinical Trials Review 2014 - Profiles of 10 Companies & 9 ...
read story
Research and Markets has announced the addition of the "Malignant Mesothelioma Global Clinical Trials Review, H1, 2014
 
20 years of data shows treatment technique improvement for advanced abdominal cancer
read story
( Wake Forest Baptist Medical Center ) Wake Forest Baptist has the largest reported, single-center experience with cytoreductive surgery and HIPEC and analysis of 20 years' worth of patient data shows that outcomes have clearly improved for patients undergoing this treatment technique.
 
MRHFM Advocates for the 2014 International Symposium on Malignant Mesothelioma in Washington D.C.
read story
The law firm of MRHFM supports the 11th Annual International Symposium on Malignant Mesothelioma as it relates to funding mesothelioma cancer research. (PRWeb April 10, 2014) Read the full story at http://www.prweb.com/releases/MRHFM-Advocates/Mesothelioma-Symposium/prweb11719869.htm
 
Phase II Study Finds Lower-Cost Mesothelioma Drug Safe and Effective, According to Surviving Mesothelioma
read story
Mexican researchers say an alternative to the standard mesothelioma chemotherapy regimen can not only improve survival and quality of life, but can also save money. (PRWeb April 10, 2014) Read the full story at http://www.prweb.com/releases/2014/04/prweb11733324.htm
 
Italy's MolMed close to announcing cancer drug results
read story
Italy's MolMed is close to presenting results from Phase III clinical trials of a new cancer treatment that could represent a turning point for the biotech company, its founder said on Wednesday. The Milan-based company has developed the NGR-hTNF molecule to treat mesothelioma, a cancer caused by asbestos, and expects to announce results of the trials by the end of June, Claudio Bordignon told ...
 
Press Release
read story
Verastem Inc. Posted on: 25 Mar 14 Verastem Inc. (NASDAQ:VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells announced that the Company will present data at the upcoming American Association of Cancer Research (AACR) meeting to be held April 5-9 2014 at the San Diego Convention Center in San Diego CA.
 
Mesothelioma Compensation Center Creates New Vital Tip Needed To Ensure The Best Compensation For US Navy Veterans ...
read story
The Mesothelioma Compensation Center is now releasing a tip sheet that contains a valuable new tip on what treatment centers they feel are the best in the nation, as well as many other vital tips released previously that are still important. US Navy Veterans, individuals, or their family members, dealing with a mesothelioma diagnosis are encouraged to call the Mesothelioma Compensation Center ...
 
Verastem to Present Data on Product Candidates Targeting Cancer Stem Cells at the American Association of Cancer ...
read story
Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that the Company will present data
 
High Risk Workers May Benefit from New Mesothelioma Research, According to Cancer Monthly
read story
Japanese cancer researchers say a simple blood test could help pinpoint the people at highest risk for mesothelioma in a large group of at-risk workers. (PRWeb April 03, 2014) Read the full story at http://www.prweb.com/releases/2014/03/prweb11713506.htm